Jang Mijung, Yoon Young Il, Kwon Yong Soo, Yoon Tae-Jong, Lee Hak Jong, Hwang Sung Il, Yun Bo La, Kim Sun Mi
Department of Radiology, Seoul National University Bundang Hospital, Seongnam 463-707, Korea.
Nanoimaging and Therapy Research Center, Institute of Nanoconvergence, Advanced Institutes of Convergence Technology, Seoul National University, Suwon 443-270, Korea.
Korean J Radiol. 2014 Jul-Aug;15(4):411-22. doi: 10.3348/kjr.2014.15.4.411. Epub 2014 Jul 9.
OBJECTIVE: To synthesize mesoporous silica-core-shell magnetic nanoparticles (MNPs) encapsulated by liposomes (Lipo [MNP@m-SiO2]) in order to enhance their stability, allow them to be used in any buffer solution, and to produce trastuzumab-conjugated (Lipo[MNP@m-SiO2]-Her2Ab) nanoparticles to be utilized in vitro for the targeting of breast cancer. MATERIALS AND METHODS: The physiochemical characteristics of Lipo[MNP@m-SiO2] were assessed in terms of size, morphological features, and in vitro safety. The multimodal imaging properties of the organic dye incorporated into Lipo[MNP@m-SiO2] were assessed with both in vitro fluorescence and MR imaging. The specific targeting ability of trastuzumab (Her2/neu antibody, Herceptin®)-conjugated Lipo[MNP@m-SiO2] for Her2/neu-positive breast cancer cells was also evaluated with fluorescence and MR imaging. RESULTS: We obtained uniformly-sized and evenly distributed Lipo[MNP@m-SiO2] that demonstrated biological stability, while not disrupting cell viability. Her2/neu-positive breast cancer cell targeting by trastuzumab-conjugated Lipo[MNP@m-SiO2] was observed by in vitro fluorescence and MR imaging. CONCLUSION: Trastuzumab-conjugated Lipo[MNP@m-SiO2] is a potential treatment tool for targeted drug delivery in Her2/neu-positive breast cancer.
目的:合成脂质体包裹的介孔二氧化硅核壳磁性纳米颗粒(MNPs,脂质体[MNP@m-SiO2]),以提高其稳定性,使其能在任何缓冲溶液中使用,并制备曲妥珠单抗偶联的(脂质体[MNP@m-SiO2]-Her2Ab)纳米颗粒用于体外靶向乳腺癌。 材料与方法:从尺寸、形态特征和体外安全性方面评估脂质体[MNP@m-SiO2]的理化特性。通过体外荧光和磁共振成像评估掺入脂质体[MNP@m-SiO2]的有机染料的多模态成像特性。还用荧光和磁共振成像评估曲妥珠单抗(Her2/neu抗体,赫赛汀®)偶联的脂质体[MNP@m-SiO2]对Her2/neu阳性乳腺癌细胞的特异性靶向能力。 结果:我们获得了尺寸均匀且分布均匀的脂质体[MNP@m-SiO2],其具有生物稳定性,同时不破坏细胞活力。通过体外荧光和磁共振成像观察到曲妥珠单抗偶联的脂质体[MNP@m-SiO2]对Her2/neu阳性乳腺癌细胞的靶向作用。 结论:曲妥珠单抗偶联的脂质体[MNP@m-SiO2]是Her2/neu阳性乳腺癌靶向药物递送的潜在治疗工具。
Int J Nanomedicine. 2011-9-14
Int J Nanomedicine. 2012-4-17
Appl Mater Today. 2023-8
Pharmaceutics. 2023-2-17
Cancers (Basel). 2022-5-13
Inorg Chem Commun. 2021-12
Nanomaterials (Basel). 2020-8-26
Environ Sci Pollut Res Int. 2018-9-8
J Magn Reson Imaging. 2012-10
Acc Chem Res. 2011-8-17
Proc Natl Acad Sci U S A. 2009-7-28